156 related articles for article (PubMed ID: 12869800)
1. Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus.
Nappi RE; Sances G; Brundu B; Ghiotto N; Detaddei S; Biancardi C; Polatti F; Nappi G
Neuroendocrinology; 2003 Jul; 78(1):52-60. PubMed ID: 12869800
[TBL] [Abstract][Full Text] [Related]
2. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.
Nappi RE; Sances G; Brundu B; De Taddei S; Sommacal A; Ghiotto N; Polatti F; Nappi G
Hum Reprod; 2005 Dec; 20(12):3423-8. PubMed ID: 16123089
[TBL] [Abstract][Full Text] [Related]
3. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated.
Gordon ML; Lipton RB; Brown SL; Nakraseive C; Russell M; Pollack SZ; Korn ML; Merriam A; Solomon S; van Praag HM
Cephalalgia; 1993 Dec; 13(6):400-5. PubMed ID: 8313453
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
[TBL] [Abstract][Full Text] [Related]
5. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.
Su TP; Schmidt PJ; Danaceau M; Murphy DL; Rubinow DR
J Clin Endocrinol Metab; 1997 Apr; 82(4):1220-8. PubMed ID: 9100599
[TBL] [Abstract][Full Text] [Related]
6. The m-chlorophenylpiperazine test in cluster headache: a study on central serotoninergic activity.
Leone M; Attanasio A; Croci D; Libro G; Grazzi L; D'Amico D; Nespolo A; Bussone G
Cephalalgia; 1997 Oct; 17(6):666-72. PubMed ID: 9350388
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test.
Leone M; Attanasio A; Croci D; Ferraris A; D'Amico D; Grazzi L; Nespolo A; Bussone G
Neuroreport; 1998 Aug; 9(11):2605-8. PubMed ID: 9721941
[TBL] [Abstract][Full Text] [Related]
8. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.
Pallanti S; Bernardi S; Quercioli L; DeCaria C; Hollander E
CNS Spectr; 2006 Dec; 11(12):956-64. PubMed ID: 17146409
[TBL] [Abstract][Full Text] [Related]
9. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
Hollander E; Cohen LJ; DeCaria C; Saoud JB; Stein DJ; Cooper TB; Islam NN; Liebowitz MR; Klein DF
Biol Psychiatry; 1993 Sep; 34(6):407-13. PubMed ID: 8218609
[TBL] [Abstract][Full Text] [Related]
10. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.
Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V
Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871
[TBL] [Abstract][Full Text] [Related]
11. Hormonal responses to meta-chlorophenylpiperazine (m-CPP) are undiminished by acute m-CPP pretreatment.
Coccaro EF; Kavoussi RJ; Trestman RL; Gabriel SM; Cooper TB; Siever LJ
Psychiatry Res; 1996 May; 62(2):139-45. PubMed ID: 8771611
[TBL] [Abstract][Full Text] [Related]
12. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
[TBL] [Abstract][Full Text] [Related]
13. The effects of gender and gonadal steroids on the neuroendocrine and temperature response to m-chlorophenylpiperazine in leuprolide-induced hypogonadism in women and men.
Schmidt PJ; Raju J; Danaceau M; Murphy DL; Berlin RE
Neuropsychopharmacology; 2002 Nov; 27(5):800-12. PubMed ID: 12431854
[TBL] [Abstract][Full Text] [Related]
14. Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa.
Steiger H; Gauvin L; Israël M; Koerner N; Ng Ying Kin NM; Paris J; Young SN
Arch Gen Psychiatry; 2001 Sep; 58(9):837-43. PubMed ID: 11545666
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
Mueller EA; Murphy DL; Sunderland T
J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
[TBL] [Abstract][Full Text] [Related]
16. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.
Bagdy G; Arato M
Psychopharmacology (Berl); 1998 Apr; 136(4):342-8. PubMed ID: 9600579
[TBL] [Abstract][Full Text] [Related]
17. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls.
Garcia-Borreguero D; Jacobsen FM; Murphy DL; Joseph-Vanderpool JR; Chiara A; Rosenthal NE
Biol Psychiatry; 1995 May; 37(10):740-9. PubMed ID: 7640329
[TBL] [Abstract][Full Text] [Related]
18. Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence.
Patkar AA; Mannelli P; Peindl K; Hill KP; Wu LT; Lee T; Kuhn C
J Psychiatr Res; 2008 Oct; 42(14):1213-9. PubMed ID: 18321529
[TBL] [Abstract][Full Text] [Related]
19. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
[TBL] [Abstract][Full Text] [Related]
20. [Diurnal beta-endorphin rhythm in relation to menstrual cycle phase].
Graf M; Distler W; Flecken A
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():121-4. PubMed ID: 2522901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
